The reperfusion time points addressed in this study were chosen to investigate the anti-inflammatory capacities of EPO in the acute and subacute phase after ischemic stroke and to allow potential comparisons with our previous data and several (pre)clinical studies [20, 55]. The gene discussed is EPO; the disease is ischemic stroke.